CINF
43
2
AAPL
42
2
NWSA
80
-4
HAL
46
-4
APH
65
-6
SRE
49
4
AME
47
-6
SLG
48
-2
FLR
59
-9
ICE
60
7
OKE
49
4
IR
63
-2
SWK
37
-2
FITB
58
-10
AEP
64
3
URI
63
-3
CHD
32
-2
ABBV
64
-2
EBAY
57
3
VIX
46
2
CINF
43
2
AAPL
42
2
NWSA
80
-4
HAL
46
-4
APH
65
-6
SRE
49
4
AME
47
-6
SLG
48
-2
FLR
59
-9
ICE
60
7
OKE
49
4
IR
63
-2
SWK
37
-2
FITB
58
-10
AEP
64
3
URI
63
-3
CHD
32
-2
ABBV
64
-2
EBAY
57
3
VIX
46
2
Financhill
Back

Timothy Plan High Dividend Stock ETF Vs. Nektar Therapeutics Industry Stock Comparison

Buy
60

TPHD
Timothy Plan High Dividend Stock ETF

Last Price:
$38.56
Seasonality Move:
1.13%
Sell
50

NKTR
Nektar Therapeutics

Last Price:
$24.81
Seasonality Move:
3.02%
Buy
60
Timothy Plan High Dividend Stock ETF (TPHD) is a Buy

Is Timothy Plan High Dividend Stock ETF a Buy, Sell or Hold?

  • The current Timothy Plan High Dividend Stock ETF [TPHD] share price is $38.59. The Score for TPHD is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • TPHD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $24.94. The Score for NKTR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TPHD Stock Price Chart

What is Timothy Plan High Dividend Stock ETF's stock price today?

  • The Timothy Plan High Dividend Stock ETF share price today is $38.59
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TPHD is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $24.94
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.

TPHD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.69 Buy
Relative Strength Index (14 RSI): 59.59 Buy
Chaikin Money Flow: 729 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.58 - 38.54) Buy
Bollinger Bands (100): (35.83 - 38.17) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.94 Buy
Relative Strength Index (14 RSI): 61.37 Buy
Chaikin Money Flow: -806986 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.12 - 28.1) Buy
Bollinger Bands (100): (7.45 - 19.09) Buy

TPHD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.49 Buy
20-day SMA: 38.18 Buy
50-day SMA: 37.61 Buy
200-day SMA: 37.33 Buy
8-day EMA: 34.46 Buy
20-day EMA: 22.85 Buy
50-day EMA: 11.64 Buy
200-day EMA: 3.31 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.68 Buy
20-day SMA: 23.57 Buy
50-day SMA: 15.44 Buy
200-day SMA: 14.73 Buy
8-day EMA: 22.26 Buy
20-day EMA: 14.62 Buy
50-day EMA: 7.42 Buy
200-day EMA: 2.11 Buy

Timothy Plan High Dividend Stock ETF Earnings Growth & TPHD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.99 per share, and a decrease next year of $1.16 per share.

Timothy Plan High Dividend Stock ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):